Lai Wang Insider Profile
4 Followers
Lai Wang, President, Global Head of R&D at BeOne Medicines, holds 2.28M shares in BeOne Medicines (Ticker: ONC). Most recently, Lai Wang Sold 1,068 shares of BeOne Medicines on Jun 25, 2026 for an estimated value of $295.55K.
Lai Wang BeOne Medicines (ONC)President, Global Head of R&D
BeOne Medicines (ONC)
President, Global Head of R&D
Ranked #47,631 out of 108,079 Corporate Insiders
Profitable Transactions
6 out of 18 Profitable Transactions
Average Return
+0.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
President, Global Head of R&D
Roles that Lai Wang holds in companies
Most Profitable Insider Trade
The most profitable trade made by Lai Wang
Lai Wang's Trading History
List of latest transactions for each holding click on a transaction to see Lai Wang's performance on stock
You May Also Like
Lai Wang insider profile FAQ
What is the percentage of profitable transactions made by Lai Wang?
The percentage of profitable transactions made by Lai Wang is 33%.
What is the average return per transaction made by Lai Wang?
The average return per transaction made by Lai Wang is 0.40%.
What stocks does Lai Wang hold?
Lai Wang holds: ONC stocks.
What was Lai Wang’s latest transaction?
Lai Wang latest transaction was an Informative Sell of $295.55K.
What was Lai Wang's most profitable transaction?
Lai Wang’s most profitable transaction was an Informative Sell of ONC stock on June 9, 2021. The return on the trade was 56.60%.
What is Lai Wang's role in BeOne Medicines?
Lai Wang's role in BeOne Medicines is President, Global Head of R&D.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.